Affymax(R) to Present at the Natexis Bleichroeder Hidden Gems Conference.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Affymax, Inc. (Nasdaq:AFFY) today announced that Paul Cleveland, the company's executive vice president and chief financial officer, will present at the Natexis Bleichroeder Hidden Gems Conference, Monday, October 8, 2007, at 3:45 p.m. Eastern Daylight Time in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . A live webcast of the presentation will be available on the Investors section of the company's website at www.affymax.com. A replay will also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide[TM], is currently in Phase 3 clinical trial phase 3 clinical trial Phase 3 study. See Phase study. stage for the treatment of anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin associated with chronic renal failure chronic renal failure Chronic kidney failure Nephrology A slow decline in renal function, which may be 2º to chronic HTN, DM, CHF, SLE, or sickle cell anemia and, if extreme, leads to ESRD, mandating kidney dialysis; an abrupt decline in renal function may be and in clinical trials for the treatment of anemia in cancer patients. For additional information, please visit www.affymax.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion